| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 3333225 | Revue d'Oncologie Hématologie Pédiatrique | 2015 | 13 Pages | 
Abstract
												Our study shows that outcome of infants is comparable with those of older patients with a treatment based on intensive chemotherapy and allogenic BMT if necessary. Autologous BMT is not recommended.
											Keywords
												
											Related Topics
												
													Life Sciences
													Immunology and Microbiology
													Immunology
												
											Authors
												L. Le Mouël, A. Auvrignon, C. Ragu, Y. Réguerre, G. Leverger, 
											